lung cancer | |||||
新闻 | |||||
CHMP Recommends 15 Medicines, Extends Six Indications ... for Opdivo (nivolumab) plus Yervoy (ipilimumab) for first-line treatment of advanced non-small cell lung cancer, noting that CHMP "determined a full ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment